A case of fulminant hepatitis cured with the glucagon-insulin treatment

A 17-year-old male patient with fulminant hepatitis who could be cured with the glucagon-insulin (G-I) treatment is reported. The patient was severely jaundiced (total scrum bilirubin 12.6mg/dl), his serum alanine aminotransferase 828 units, blood ammonia 101μg/dl and both HBs antigen and HBs antibo...

Full description

Saved in:
Bibliographic Details
Published inKanzo Vol. 21; no. 10; pp. 1352 - 1357
Main Authors HOSOKAWA, Yukio, SUGA, Mitsuo, YOKOYAMA, Yoko, KINOSHITA, Hiroshi, ANZAI, Tetsuro, FUJISAWA, Yasunori, FUJISHIMA, Akira, FUJITA, Hideo, SAITO, Michiko
Format Journal Article
LanguageJapanese
Published The Japan Society of Hepatology 1980
Subjects
AFP
Online AccessGet full text

Cover

Loading…
Abstract A 17-year-old male patient with fulminant hepatitis who could be cured with the glucagon-insulin (G-I) treatment is reported. The patient was severely jaundiced (total scrum bilirubin 12.6mg/dl), his serum alanine aminotransferase 828 units, blood ammonia 101μg/dl and both HBs antigen and HBs antibody were simultaneously detected with the radioimmunoassay. Intensive parenteral administrations of prednisolone and l-DOPA, combined with rectal applications of lactulose, proved ineffective in preventing from his Grade III (Adams and Foley) hepatic encephalopathy with asterexis. The G-I treatment was therefore started, which resulted in awakening from coma with a decrease of blood ammonia. During the clinical course, serum AFP level was as high as 782ng/ml, and the liver biopsy specimen obtained after recovery showed cirrhosis of the liver. The mechanism by which the G-I treatment favours the fulminant hepatic disorder was discussed.
AbstractList A 17-year-old male patient with fulminant hepatitis who could be cured with the glucagon-insulin (G-I) treatment is reported. The patient was severely jaundiced (total scrum bilirubin 12.6mg/dl), his serum alanine aminotransferase 828 units, blood ammonia 101μg/dl and both HBs antigen and HBs antibody were simultaneously detected with the radioimmunoassay. Intensive parenteral administrations of prednisolone and l-DOPA, combined with rectal applications of lactulose, proved ineffective in preventing from his Grade III (Adams and Foley) hepatic encephalopathy with asterexis. The G-I treatment was therefore started, which resulted in awakening from coma with a decrease of blood ammonia. During the clinical course, serum AFP level was as high as 782ng/ml, and the liver biopsy specimen obtained after recovery showed cirrhosis of the liver. The mechanism by which the G-I treatment favours the fulminant hepatic disorder was discussed.
Author KINOSHITA, Hiroshi
ANZAI, Tetsuro
SUGA, Mitsuo
SAITO, Michiko
YOKOYAMA, Yoko
FUJISHIMA, Akira
FUJISAWA, Yasunori
HOSOKAWA, Yukio
FUJITA, Hideo
Author_xml – sequence: 1
  fullname: HOSOKAWA, Yukio
  organization: Department of Internal Medicine, Muroran City General Hospital
– sequence: 2
  fullname: SUGA, Mitsuo
  organization: Department of Internal Medicine (Section 1) Sapporo Medical College
– sequence: 3
  fullname: YOKOYAMA, Yoko
  organization: Department of Internal Medicine, Muroran City General Hospital
– sequence: 4
  fullname: KINOSHITA, Hiroshi
  organization: Department of Internal Medicine, Muroran City General Hospital
– sequence: 5
  fullname: ANZAI, Tetsuro
  organization: Department of Internal Medicine, Muroran City General Hospital
– sequence: 6
  fullname: FUJISAWA, Yasunori
  organization: Department of Clinical Pathology, Muroran City General Hospital
– sequence: 7
  fullname: FUJISHIMA, Akira
  organization: Department of Internal Medicine (Section 1) Sapporo Medical College
– sequence: 8
  fullname: FUJITA, Hideo
  organization: Department of Internal Medicine (Section 1) Sapporo Medical College
– sequence: 9
  fullname: SAITO, Michiko
  organization: Department of Internal Medicine (Section 1) Sapporo Medical College
BookMark eNo9kEtPAjEUhRuDiYgs3fcPDPa286BLQhRISNzoetJpb5nq0CFtJ0Z_vTyUzT2b75ybfPdk5HuPhDwCm3FZVE-fyv_0Mw4zEAW_IWOYzyEThRQjMmZ5AVnOmbgj0xhdwxgvKyYlH5PVgmoVkfaW2qHbO698oi0eVHLJRaqHgIZ-udTS1CLddYNWu95nzsehc56mgCrt0acHcmtVF3H6lxPy_vL8tlxn29fVZrnYZhqO_zLFS1MgWCtMLitprK4AjCxKCYpbWVVcGdRNg9aUnHNjGADTrMiFNCibXExIdtnVoY8xoK0Pwe1V-K6B1ScR9VlEzaE-iTjy6wv_EZPa4ZVWITnd4YUGWbJz4_-eqldEtyrU6MUvZ9lt4w
ContentType Journal Article
Copyright The Japan Society of Hepatology
Copyright_xml – notice: The Japan Society of Hepatology
DBID AAYXX
CITATION
DOI 10.2957/kanzo.21.1352
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1881-3593
EndPage 1357
ExternalDocumentID 10_2957_kanzo_21_1352
article_kanzo1960_21_10_21_10_1352_article_char_en
GroupedDBID AAOTG
ALMA_UNASSIGNED_HOLDINGS
CS3
JSF
KQ8
P2P
RJT
2WC
AAYXX
CITATION
OK1
ID FETCH-LOGICAL-c1992-a26d5e1ff3d4979dfc711d95691a2f9772adecbbefd6222dd0110c05439de9b43
ISSN 0451-4203
IngestDate Fri Aug 23 00:37:50 EDT 2024
Wed Apr 05 14:38:04 EDT 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c1992-a26d5e1ff3d4979dfc711d95691a2f9772adecbbefd6222dd0110c05439de9b43
OpenAccessLink https://www.jstage.jst.go.jp/article/kanzo1960/21/10/21_10_1352/_article/-char/en
PageCount 6
ParticipantIDs crossref_primary_10_2957_kanzo_21_1352
jstage_primary_article_kanzo1960_21_10_21_10_1352_article_char_en
PublicationCentury 1900
PublicationDate 1980
PublicationDateYYYYMMDD 1980-01-01
PublicationDate_xml – year: 1980
  text: 1980
PublicationDecade 1980
PublicationTitle Kanzo
PublicationTitleAlternate Kanzo
PublicationYear 1980
Publisher The Japan Society of Hepatology
Publisher_xml – name: The Japan Society of Hepatology
References 12) 沖田極他:肝疾患治療薬の作用に関する基礎的研究(2).重症肝炎の治療を目的としたglucagon-insulin療法の基礎的研究.肝臓,19: 848, 1978.
6) Soeters, P.B. & Fischer, J.E.: Insulin, glucagon, aminoacid imbalance, and hepatic encephalopathy. Lancet, II: 880, 1976.
10) Starzl, T.E.: Effects of insulin, glucagon, and insulin/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet, I: 821, 1976.
5) 安斎哲郎:肝性脳症について.市立室蘭医誌,4: 1, 1979.
4) Bucher, N.L.R. & Swaffeld, M.N.: Regulation of hepatic regeneration in rats by synergistic action of insulin and glucagon. Proc. Nat, Acad. Sci. USA, 72: 1157, 1975.
11) Price, J.B.: Glucagon as the portal factor modifying hepatic regeneration. Surgery, 72: 74, 1972.
7) Munro, H.N.: Insulin, plasma aminoacid imbalance, and hepatic coma. Lancet, I: 722, 1975.
15) Murray-Lyon, I.M.: Prognostic value of serum alpha-fetoprotein in fulminant hepatic failure including Patients treated by charcoal haemoperfusion. Gut, 17: 576, 1976.
2) Trey, C.: The fulminant hepatic failure surveillance study. Brief review of thc effects of presumed etiology and age of survival. Canad. Med. Ass. J., 106: 525, 1972.
8) Fischer, J.E. & Baldessarini, R.J.: False neurotransmitters and hepatic failure. Lancet, II: 75, 1971.
13) 沖田極他:肝疾患治療薬の作用に関する基礎的研究(3). glucagon-insulin療法による急性,慢性肝不全の治療.肝臓,19: 854,1978.
14) 菅充生他:高AFP値を示した亜急性肝壊死の1例.日内会誌,65: 183, 1976.
1) 高橋善弥太他:劇症肝炎の全国集計,第9回犬山シンポジウム記録集,中外医学社,東京,1977, p.3.
3) Adams, R.D. & Foley, J.M.: The neurological disorder associated with liver disease. Res. Publ. Ass. Res. Nerv. Ment, Dis., 32: 198, 1953.
16) Karvountzis, G.G. & Redeker, A.G.: Relation of alpha-fetoprotein in acute hepatitis to severity and prognosis. Ann. Int. Med., 80: 156, 1974.
9) Snodgrass, P.J.: Induction of urea cycle enzymes of rat liver by glucagon. J. Biol. Chem., 253: 2748, 1978
References_xml
SSID ssib002670992
ssib000940394
ssib002670224
ssj0069113
ssib005879686
ssib002484534
ssib031783187
Score 1.2772974
Snippet A 17-year-old male patient with fulminant hepatitis who could be cured with the glucagon-insulin (G-I) treatment is reported. The patient was severely...
SourceID crossref
jstage
SourceType Aggregation Database
Publisher
StartPage 1352
SubjectTerms AFP
Title A case of fulminant hepatitis cured with the glucagon-insulin treatment
URI https://www.jstage.jst.go.jp/article/kanzo1960/21/10/21_10_1352/_article/-char/en
Volume 21
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Kanzo, 1980/10/25, Vol.21(10), pp.1352-1357
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELfKQIgXxKcYX_ID4mVKiZ0Px48RgnVUW4Taiu2pcuJkdEXNtCUv_A_8z9zZiZuiPTDEi9U4diTfXc9359-dCXmHlxTxgpeeyGXshSyJvTyKKw_2hkpyxbVUmOB8fBJPFuGX0-h0NPo1QC21TT4uft6YV_IvXIU-4Ctmyd6Cs-6j0AG_gb_QAoeh_SsepweFsrH4qv1hMS1g-SFGulldHxStw5ajdYngdHVeb7wefu4w5kMDdQq2Yu14nc2yafotNXq6Xa_ci9niMLWg--a6db1n2TQ7w5A9Dq_Xrn96dJLNJkdz82Kygn35-2obbWDSXrI0dplqsH9vHJwUDxpwSdvwv1VbYQReKfet2iqtWk0S5gWRvQux17s2M7qXL3-gRVlgq9p2OzI8ipu0PZfmiuI1EmbM2Xg7baeAdseepRkHCsdfcrZkfYuTlv0QzHQDwbpD7nIBjiOe8X8dWKsy9IOhNxwmYRQMvVmBFtHOsxwcWkeJkPG2Wh9YbgloVBcfiGHfMYCInoC2JCyu8sPOGndMqHsX4EX0CERjFM0fkYedN0NTu7DHZHShnpD7xx1e4yk5TClKKK0r6iSUOgmlRkIpSigFCaV_Sih1EvqMLD5_mn-ceN3VHV5h8MyKxzoqWVUFOpRC6qoQjGkgqWSKV-BzcKXLIs_LSsdgoWqNZmgB7kMgdSnzMHhO9jb1pnxBqJ9rCZtSESgRhKVIVOyrSmLRIiFwxj5531NjeWkrtBjuAtksyw2jgWz7JLW0csNuLxkv_8M3XpEH-M-ycbzXZK-5ass3YNk2-Vsjb78BG6ydfA
link.rule.ids 315,786,790,4043,27956,27957,27958
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+case+of+fulminant+hepatitis+cured+with+the+glucagon-insulin+treatment&rft.jtitle=Kanzo&rft.au=HOSOKAWA%2C+Yukio&rft.au=SUGA%2C+Mitsuo&rft.au=YOKOYAMA%2C+Yoko&rft.au=KINOSHITA%2C+Hiroshi&rft.date=1980&rft.pub=The+Japan+Society+of+Hepatology&rft.issn=0451-4203&rft.eissn=1881-3593&rft.volume=21&rft.issue=10&rft.spage=1352&rft.epage=1357&rft_id=info:doi/10.2957%2Fkanzo.21.1352&rft.externalDocID=article_kanzo1960_21_10_21_10_1352_article_char_en
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0451-4203&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0451-4203&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0451-4203&client=summon